LU73993A1 - - Google Patents

Info

Publication number
LU73993A1
LU73993A1 LU73993A LU73993A LU73993A1 LU 73993 A1 LU73993 A1 LU 73993A1 LU 73993 A LU73993 A LU 73993A LU 73993 A LU73993 A LU 73993A LU 73993 A1 LU73993 A1 LU 73993A1
Authority
LU
Luxembourg
Application number
LU73993A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU73993A1 publication Critical patent/LU73993A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
LU73993A 1974-12-13 1975-12-11 LU73993A1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2458965A DE2458965C3 (de) 1974-12-13 1974-12-13 3-Amino-indazol-N-carbonsäure-Derivate, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
LU73993A1 true LU73993A1 (xx) 1976-11-11

Family

ID=5933305

Family Applications (1)

Application Number Title Priority Date Filing Date
LU73993A LU73993A1 (xx) 1974-12-13 1975-12-11

Country Status (27)

Country Link
US (1) US4051252A (xx)
JP (1) JPS5182266A (xx)
AT (1) AT343653B (xx)
BE (1) BE836528A (xx)
CA (1) CA1059523A (xx)
CH (1) CH622250A5 (xx)
CS (1) CS189731B2 (xx)
DD (1) DD125484A5 (xx)
DE (1) DE2458965C3 (xx)
DK (1) DK137082C (xx)
ES (1) ES443429A1 (xx)
FI (1) FI753493A (xx)
FR (1) FR2293928A1 (xx)
GB (1) GB1490306A (xx)
HK (1) HK52580A (xx)
HU (1) HU173557B (xx)
IE (1) IE42208B1 (xx)
IL (1) IL48642A (xx)
KE (1) KE3078A (xx)
LU (1) LU73993A1 (xx)
NL (1) NL7514521A (xx)
NO (1) NO145382C (xx)
PL (1) PL99858B1 (xx)
SE (1) SE419645B (xx)
SU (1) SU604487A3 (xx)
YU (1) YU315275A (xx)
ZA (1) ZA757777B (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431657A (en) * 1982-05-24 1984-02-14 Ayerst, Mckenna & Harrison Inc. Analgesic compositions consisting of 2H-benzothieno[3,2-c]pyrazol-3-amine derivatives
KR20010086657A (ko) * 2000-03-02 2001-09-15 성재갑 아미노인다졸 유도체 및 이를 함유하는 싸이클린 의존키나아제 저해제 조성물
ATE326458T1 (de) * 2000-09-15 2006-06-15 Vertex Pharma Pyrazolverbindungen als protein-kinasehemmer
US7473691B2 (en) * 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
ZA200301701B (en) * 2000-09-15 2004-03-01 Vertex Pharma Pyrazole compounds useful as protein kinase inhibitors.
EP1698627A1 (en) * 2000-09-15 2006-09-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
DK1353916T3 (da) * 2000-12-21 2007-01-29 Vertex Pharma Pyrazolforbindelser der er egnede som proteinkinaseinhibitorer
KR100406634B1 (ko) * 2001-03-12 2003-11-20 주식회사 엘지생명과학 3,5-디아미노인다졸 유도체, 그의 제조방법 및 사이클린의존성 키나아제 저해제로서의 그의 용도
EA007430B1 (ru) 2001-09-26 2006-10-27 Фармация Италия С.П.А. Производные аминоиндазола, активные в качестве ингибиторов киназ, способ их получения и содержащая их фармацевтическая композиция
SG159380A1 (en) * 2002-02-06 2010-03-30 Vertex Pharma Heteroaryl compounds useful as inhibitors of gsk-3
FR2836915B1 (fr) 2002-03-11 2008-01-11 Aventis Pharma Sa Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US20040009981A1 (en) 2002-03-15 2004-01-15 David Bebbington Compositions useful as inhibitors of protein kinases
CA2486101C (en) 2002-05-17 2009-07-07 Pharmacia Italia S.P.A. Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
MY141867A (en) * 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
CN101037438A (zh) 2002-08-02 2007-09-19 沃泰克斯药物股份有限公司 用作gsk－3的抑制剂的吡唑组合物
CA2502429A1 (en) * 2002-10-31 2004-05-21 Amgen Inc. Antiinflammation agents
US7601718B2 (en) 2003-02-06 2009-10-13 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
WO2005056547A2 (en) * 2003-12-04 2005-06-23 Vertex Pharmaceuticals Incorporated Quinoxalines useful as inhibitors of protein kinases
DE102004005172A1 (de) * 2004-02-02 2005-08-18 Aventis Pharma Deutschland Gmbh Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
AU2006279376B2 (en) 2005-08-18 2011-04-14 Vertex Pharmaceuticals Incoporated Pyrazine kinase inhibitors
NZ594385A (en) * 2005-11-03 2013-02-22 Vertex Pharma Aminopyrimidines useful as kinase inhibitors
WO2007121339A2 (en) * 2006-04-14 2007-10-25 Abbott Laboratories Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (vr1) receptors
MX2009004807A (es) 2006-11-02 2009-06-15 Vertex Pharma Aminopiridinas y aminopirimidinas utiles como inhibidores de proteina cinasa.
DE602007007985D1 (de) 2006-12-19 2010-09-02 Vertex Pharma Als inhibitoren von proteinkinasen geeignete aminopyrimidine
EP2134709A1 (en) 2007-03-09 2009-12-23 Vertex Pharmaceuticals, Inc. Aminopyridines useful as inhibitors of protein kinases
AU2008226466B2 (en) 2007-03-09 2013-06-13 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as inhibitors of protein kinases
JP5520057B2 (ja) 2007-03-09 2014-06-11 バーテックス ファーマシューティカルズ インコーポレイテッド 蛋白キナーゼの阻害剤として有用なアミノピリミジン
CN101679386A (zh) 2007-04-13 2010-03-24 沃泰克斯药物股份有限公司 可用作激酶抑制剂的氨基嘧啶类化合物
AU2008247594A1 (en) 2007-05-02 2008-11-13 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
EP2152694A2 (en) * 2007-05-02 2010-02-17 Vertex Pharmaceuticals Incorporated Thiazoles and pyrazoles useful as kinase inhibitors
JP5572087B2 (ja) * 2007-05-02 2014-08-13 バーテックス ファーマシューティカルズ インコーポレイテッド キナーゼ阻害として有用なアミノピリミジン
AU2008257044A1 (en) * 2007-05-24 2008-12-04 Vertex Pharmaceuticals Incorporated Thiazoles and pyrazoles useful as kinase inhibitors
EP2176261B1 (en) * 2007-07-31 2012-12-19 Vertex Pharmaceuticals Incorporated Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
JP2012501971A (ja) * 2008-09-03 2012-01-26 バーテックス ファーマシューティカルズ インコーポレイテッド 共結晶および共結晶を含む薬学的処方物
DE102009004245A1 (de) 2009-01-09 2010-07-15 Bayer Schering Pharma Aktiengesellschaft Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung
DK2890684T3 (en) 2012-07-24 2018-05-07 Bial Portela & Ca Sa URINARY COMPOUNDS AND THEIR USE AS ENZYMINE INHIBITORS
BR112015001769A2 (pt) * 2012-07-27 2017-08-22 Bial Portela & Ca Sa Processo para a síntese de compostos de ureia substituída
JP6449277B2 (ja) 2013-07-24 2019-01-09 ビアル−ポルテラ エ コンパニア，ソシエダッド アノニマ イミダゾールカルボキサミドおよびｆａａｈ阻害剤としてのそれらの使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133081A (en) * 1964-05-12 J-aminoindazole derivatives
CH397698A (de) * 1961-09-08 1965-08-31 Siegfried Ag Verfahren zur Herstellung neuer 1-Carbamyl-indazole
US3277100A (en) * 1963-05-31 1966-10-04 Du Pont Novel substituted pyrazoles
NL6707299A (xx) * 1966-07-16 1968-01-17
DE1770649A1 (de) * 1968-06-15 1971-11-11 Bayer Ag Substituierte 3-Amino-indazole

Also Published As

Publication number Publication date
FR2293928A1 (fr) 1976-07-09
DE2458965B2 (de) 1979-02-22
AT343653B (de) 1978-06-12
ZA757777B (en) 1976-11-24
PL99858B1 (pl) 1978-08-31
IL48642A0 (en) 1976-02-29
FR2293928B1 (xx) 1979-09-21
SU604487A3 (ru) 1978-04-25
US4051252A (en) 1977-09-27
IE42208B1 (en) 1980-06-18
CS189731B2 (en) 1979-04-30
BE836528A (fr) 1976-06-11
HU173557B (hu) 1979-06-28
DD125484A5 (xx) 1977-04-20
DK137082C (da) 1978-06-19
GB1490306A (en) 1977-11-02
CH622250A5 (xx) 1981-03-31
ATA939775A (de) 1977-10-15
KE3078A (en) 1980-10-03
DK137082B (da) 1978-01-16
JPS5182266A (en) 1976-07-19
NO145382B (no) 1981-11-30
IE42208L (en) 1976-06-13
ES443429A1 (es) 1977-04-16
NO754024L (xx) 1976-06-15
AU8717075A (en) 1977-06-09
DK567275A (da) 1976-06-14
NL7514521A (nl) 1976-06-15
SE419645B (sv) 1981-08-17
SE7513990L (sv) 1976-06-14
HK52580A (en) 1980-09-26
NO145382C (no) 1982-03-10
YU315275A (en) 1982-02-28
FI753493A (xx) 1976-06-14
CA1059523A (en) 1979-07-31
DE2458965C3 (de) 1979-10-11
IL48642A (en) 1979-12-30
DE2458965A1 (de) 1976-06-16

Similar Documents

Publication Publication Date Title
FR2293928B1 (xx)
FR2260173A1 (xx)
DK138509C (xx)
FR2271445B1 (xx)
FR2292469B1 (xx)
AU7891375A (xx)
JPS50106673U (xx)
AU485556B2 (xx)
FR2268815B1 (xx)
IN140535B (xx)
JPS50103041U (xx)
JPS50104457U (xx)
JPS50106371U (xx)
BG19917A1 (xx)
BG21328A1 (xx)
BG21475A1 (xx)
BG20245A1 (xx)
BG21460A1 (xx)
BG21563A1 (xx)
BG20460A1 (xx)
BG21661A1 (xx)
BG21801A1 (xx)
BG20211A1 (xx)
BG21827A1 (xx)
BG20499A1 (xx)